We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WINT
6526
DELISTED
Windtree Therapeutics
WINT
0
WLYB icon
6527
John Wiley & Sons Class B
WLYB
$2.69B
-2,000
Closed -$75K
WYY icon
6528
WidePoint Corp
WYY
$97M
$0 ﹤0.01%
57
-10
-15% -$54
XBIO icon
6529
Xenetic Biosciences
XBIO
$5.84M
$0 ﹤0.01%
26
XELB icon
6530
Xcel Brands
XELB
$7.39M
-7
Closed
XYF
6531
X Financial
XYF
$193M
$0 ﹤0.01%
2
-197
-99% -$533
YJ
6532
Yunji
YJ
$5.81M
-2
Closed
YTRA icon
6533
Yatra Online
YTRA
$52.2M
$0 ﹤0.01%
200
ZVRA icon
6534
Zevra Therapeutics
ZVRA
$570M
-416
Closed -$1K
LFWD icon
6535
ReWalk Robotics
LFWD
$19.7M
$0 ﹤0.01%
3
XTIA icon
6536
XTI Aerospace
XTIA
$58.9M
0
AIFC
6537
AI Financial Corp
AIFC
$52.1M
-5
Closed
MAAS
6538
Maase Inc
MAAS
$8.03B
0
TRAW icon
6539
Traws Pharma
TRAW
$6.72M
$0 ﹤0.01%
2
XYLO
6540
DELISTED
Xylo Technologies
XYLO
0
TEN
6541
Tsakos Energy Navigation Ltd
TEN
$1.2B
-12,010
Closed -$196K
QCLS
6542
Q/C Technologies Inc
QCLS
$21.3M
0
OMCC
6543
DELISTED
Old Market Capital Corp
OMCC
-1
Closed
HURA
6544
TuHURA Biosciences
HURA
$138M
0
IRD
6545
Opus Genetics
IRD
$317M
$0 ﹤0.01%
34
ENFY
6546
DELISTED
Enlightify Inc
ENFY
$0 ﹤0.01%
83
JXG
6547
JX Luxventure
JXG
$84.3M
0
TGEN
6548
Tecogen Inc
TGEN
$95.7M
-101
Closed
DM
6549
DELISTED
Desktop Metal, Inc.
DM
-40
Closed -$4K
ICCH
6550
DELISTED
ICC Holdings, Inc.
ICCH
$0 ﹤0.01%
1

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.